HAPLN1


Summary:

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

Gene Categories:

DRUGGABLE GENOME

GO terms in HAPLN1


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF HDA GO:0030021 extracellular matrix structural constituent conferring compression resistance
BP IBA GO:0001501 skeletal system development
BP IEA GO:0007155 cell adhesion
BP IBA GO:0007417 central nervous system development
BP TAS GO:0030198 extracellular matrix organization
CC TAS GO:0005576 extracellular region
Showing 1 to 6 of 9 rows

Gene expression in normal tissue: HAPLN1

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in HAPLN1


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-1474244 Extracellular matrix organization
reactome R-HSA-3000178 ECM proteoglycans
Showing 1 to 2 of 2 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD150 RITA 2
iGMDRD560 MK-2206 3
iGMDRD424 Tamatinib 3
iGMDRD462 OSI-906 (Linsitinib) 1
Showing 1 to 4 of 28 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in HAPLN1

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​